medigraphic.com
ISSN 1527-3172 (Digital)

2020, Número 3

<< Anterior Siguiente >>

MEDICC Review 2020; 22 (3)


Biomodulina T May Restore Immunity in Older Adults

Suárez-Formigo GM, Saavedra-Hernández D

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 54-56
Archivo PDF: 70.45 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. United Nations. Report of the Second World Assembly on Ageing: Madrid, 8-12 April 2002. New York: United Nations; 2002. 72 p.

  2. National Health Statistics and Medical Records Division (CU). Anuario Estadistico de Salud 2019 [Internet]. Havana: Ministry of Public Health (CU); 2020 May [cited 2020 May 25]. 206 p. Available at: https://fi les. sld.cu/bvscuba/files/2020/05/Anuario- Electr%c3%b3nico-Espa%c3%b1ol-2019-ed -2020.pdf. Spanish.

  3. Cano-Amaro M. El envejecimiento poblacional en Cuba, desde el prisma de la epidemiología social y la ética. Anales Acad Ciencias Cuba. 2016;6(2). Spanish.

  4. Fulop T, Larbi A. Biology of aging: paving the way for healthy aging. Exp Gerontol. 2018 Jul;107:1–3.

  5. Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, et al. Immunosenescence and infl amm-aging as two sides of the same coin: friends or foes? Front Immunol. 2018 Jan;8:1960.

  6. Lang PO, Govind S, Aspinall R. Reversing T cell immunosenescence: why, who, and how. Age (Dordr). 2012 Feb 25;35(3):609–20.

  7. Saavedra D, Fuertes SA, Suárez GM, González A, Lorenzo-Luaces P, García B, et al. Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly. Exp Gerontol. 2019 Jun 13;124:110633.

  8. Saavedra D, García B, Lage A. T cell subpopulations in healthy elderly and lung cancer patients: insights from Cuban studies. Front Immunol. 2017 Feb 13;8:146.

  9. Larbi A, Fulop T. From «truly naive» to «exhausted senescent» T cells: when markers predict functionality. Cytometry Part A. 2014;85(1):25– 35.

  10. Sauce D, Appay V. Altered thymic activity in early life: how does it affect the immune system in young adults? Curr Opin Immunol. 2011 Aug;23(4):543–8.

  11. Lang PO, Samaras D. Aging adults and seasonal infl uenza: does the vitamin d status (h)arm the body? J Aging Res. 2012;2012:806198.

  12. Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R. Effectiveness of infl uenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging. 2012;7:55–64.

  13. Fulop T, Larbi A, Hirokawa K, Mocchegiani E, Lesourds B, Castle S, et al. Immunosupportive therapies in aging. Clin Interv Aging. 2007 Mar;2(1):33–54.

  14. Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):28–34.

  15. CECMED – (Center for State Control of Medications, Equipment and Medical Devices [Internet]. Havana: CECMED; c2019. Registros. Resumen de las características del producto Biomodulina T; [cited 2020 May 25]. 3 p. Available at: https:// www.cecmed.cu/registro/rcp/biomodulinar-t -fraccion-timica. Spanish.

  16. Gámez MLA, Lara RRF, Rodríguez MR, González-Quevedo MA, Fernández CR, Marzoa SN. Estudio Fase II de tratamiento de pacientes con esclerosis múltiple exacerbanteremitente con Biomodulina T. Rev Mex Neuroci. 2007;8(1):28–31. Spanish.

  17. Christian López LC, Rodríguez Marín RR, Rabassa Pérez J, Santamaría Lafargue M, Romero del Sol JM, González Ross E. Efecto de la biomodulina T 1000 sobre el timo en niños con infecciones recurrentes. Rev Cub Pediatr. 2000 Jan–Mar;72(1):3–9. Spanish.

  18. García-Orihuela M, Capdevila V, Suárez-Martínez R, Rodríguez-Rivera L, Castro-González I. Efecto de la Biomodulina T sobre las infecciones respiratorias altas y la polifarmacia del anciano. Rev Haban Cienc Méd. 2014 May– Jun;13(3):425–36. Spanish.

  19. Pido-López J, Imami N, Aspinall R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin Exp Immunol. 2001 Sep;125(3):409– 13.

  20. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011 Oct;17(10):1290–7.

  21. Saavedra D, Crombet T. CIMAvax-EGF: a new therapeutic vaccine for advanced non-small cell lung cancer patients. Front Immunol. 2017 Mar 13;8:269.

  22. Ferrara R, Mezquita L, Auclin E, Chaput N, Besse B. Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: does age really matter? Cancer Treat Rev. 2017 Nov;60:60–8.




2020     |     www.medigraphic.com